Nonetheless, the elevated expression of visfatin in peritumoral adipose tissue, together with its tumor-promoting effects demonstrated in vitro, suggests that visfatin may serve not only as a prognostic biomarker associated with tumor aggressiveness but also as a potential therapeutic target. This evidence concerns the gene NAMPT and neoplasm.